Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
First-time backers Pfizer Venture Investments and Polaris Venture Partners have led a $30mm Series E financing for Neuronetics Inc., which creates magnetic pulse-generating devices for major depression. Existing shareholders Investor Growth Capital, New Leaf Venture Partners, InterWest Partners, Three Arch Partners, Quaker BioVentures, and Onset Ventures also participated. Polaris adds a new board member, and a director from Pfizer Venture will join as an observer.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?